Cart
sales@molnova.com
Rosavin
CAS No. 84954-92-7
Rosavin( Rosavin | )
Catalog No. M19178 CAS No. 84954-92-7
Rosavin has antidepressant and anxiolytic actions, helps balance all the neurotransmitters.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 108 | In Stock |
|
| 25MG | 253 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRosavin
-
NoteResearch use only, not for human use.
-
Brief DescriptionRosavin has antidepressant and anxiolytic actions, helps balance all the neurotransmitters.
-
DescriptionRosavin is a bioactive antidepressant component isolated from Rhodiola rosea L.
-
In Vitro——
-
In Vivo——
-
SynonymsRosavin |
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCYP3A4
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number84954-92-7
-
Formula Weight428.43
-
Molecular FormulaC20H28O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (233.41 mM)
-
SMILESO1[C@H]([C@@H]([C@H]([C@@H]([C@H]1CO[C@@H]1OC[C@@H]([C@@H]([C@H]1O)O)O)O)O)O)OC/C=C/c1ccccc1
-
Chemical Name(2R,3R,4S,5S,6R)-2-(cinnamyloxy)-6-((((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Grech-Baran M1,et al. Biotechnol Lett. 2014 Mar;36(3):649-56.
molnova catalog
related products
-
VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
-
CCT-251921
A potent, selective, and orally bioavailable inhibitor of CDK8 and CDK19 with IC50of 2.3 nM and 2.6 nM respectively.
-
Purvalanol B
A potent, cell-permeable, selective inhibitor of CDK with IC50s of 6, 6, 9, and 6 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, and cdk5-p35 respectively.
